Subscribe to Newsletter

Content by Stephanie Vine:

Business & Regulation Small Molecules

Let’s Try This!

| Stephanie Vine

Innovation is the key to progress.

Business & Regulation Small Molecules

Patients Above Profits

| Stephanie Vine

Civica Rx has its eye on ANDAs.

Business & Regulation Small Molecules

Drug Shortage Demands

| Stephanie Vine

Action is required to put an end to drug shortages.

Discovery & Development Vaccines

Combating Coronavirus

| Stephanie Vine

As the new virus spreads, more information is needed to mount an appropriate response.

Manufacture Biosimilars

New Decade, New Hope

| Stephanie Vine

Cures for all presents a real focus for the next decade – but companies must be rewarded for their work.

Discovery & Development Drug Delivery

Breathing Easy

| Stephanie Vine

How will inhaled therapies evolve? Lei Mao at Recipharm gives his take on the future of these therapies.

Manufacture Small Molecules

Continuous in the Spotlight

| Stephanie Vine, Maryam Mahdi

Continuus was established with the primary objective of shining a spotlight on continuous manufacturing.

Business & Regulation Business Practice

Business in Brief

| Stephanie Vine

Continuous processing, exporting generics and alleviating drug shortages… what’s new for pharma in business?

Discovery & Development Dosage Forms

Attack of the Horse Pills

| Stephanie Vine

Why are people still being prescribed giant tablets?

Manufacture Small Molecules

Bang the Drum

| Stephanie Vine

Pharma companies have been raising awareness for years, but patients continue to buy counterfeit medicines online.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker